Med Spa Compliance for GLP-1 Prescribing: What You Need to Know

Medical spas that offer GLP-1 weight management programs are operating in one of the most scrutinized areas of medical practice today. Regulatory attention from state medical boards, the FDA, and the FTC has increased significantly. Practices that are not operating with robust compliance infrastructure are taking on substantial risk.

This post covers the key compliance requirements for med spas prescribing GLP-1 compounds — from prescriber requirements to supply chain documentation.

The most fundamental compliance requirement for a med spa offering GLP-1 prescriptions is having a licensed prescriber with appropriate authority.

Prescribing authority varies by state, but generally includes:

• Physicians (MD, DO) — universal prescribing authority
• Nurse Practitioners (NP) — prescribing authority in most states, with varying supervision requirements
• Physician Assistants (PA) — prescribing authority in most states, typically with physician oversight
• Other licensed practitioners — varies significantly by state

Many states require med spas to have a licensed physician as medical director. The medical director's role and responsibilities vary by state, but typically include:

• Oversight of clinical protocols
• Supervision of non-physician prescribers
• Responsibility for clinical quality and safety
• Availability for consultation

If your med spa does not have a properly structured medical director relationship, you are operating with significant exposure.

For 503A compounded GLP-1 prescriptions, a valid patient-prescriber relationship is required. This means:

• The prescriber has evaluated the patient
• A clinical assessment has been documented
• The prescription is based on that clinical assessment
• The prescriber is available for follow-up

Telehealth prescribing is permitted in most states, but the requirements for establishing a valid patient-prescriber relationship via telehealth vary. Know your state's rules.

Where you source your compounded GLP-1 products is a compliance decision, not just a procurement decision.

Your compounding supplier must be:

• 503A licensed for patient-specific orders, or 503B registered for office-use bulk orders
• Licensed in your state to ship compounded products
• Operating under appropriate quality standards (USP <795>/<797> for 503A; CGMP for 503B)

Maintain documentation for every compounded product you receive:

• Certificate of Analysis (COA) for each lot
• Supplier licensing documentation
• Shipping and cold-chain records
• Prescription records for 503A orders

This documentation is your first line of defense in any regulatory inquiry or litigation.

The compounding market has attracted suppliers who are not operating within the appropriate regulatory framework. Signs of a non-compliant supplier include:

• No COA available
• Cannot confirm FDA registration (for 503B claims)
• Prices that seem too good to be true
• No clear licensing information
• Unwillingness to provide documentation

Working with a non-compliant supplier exposes your practice to regulatory action, civil liability, and patient safety risks.

GLP-1 prescribing compliance is not uniform across states. Some states have enacted specific rules that affect med spa operations:

California has specific requirements for med spas, including medical director supervision requirements and specific rules around telehealth prescribing. California also has particular requirements for out-of-state compounding pharmacies shipping into the state.

Florida has enacted specific rules around aesthetic medical practices and the supervision of non-physician practitioners.

Texas has specific rules around the corporate practice of medicine that affect how med spas can be structured.

Most states have some form of regulation affecting med spa operations. The rules are changing rapidly — what was compliant 18 months ago may not be compliant today.

The FTC has increased scrutiny of health claims in medical marketing, including GLP-1 weight loss claims. Key rules:

• Substantiate all claims — weight loss claims must be supported by evidence
• Disclose material connections — if you are compensated for endorsements, disclose it
• Avoid misleading before/after — the FTC has specific rules about before/after advertising
• Do not make drug claims about compounded products

At MedClinic Partners, our founding team includes mass-tort attorneys who have litigated against pharmaceutical companies for 15+ years. We have seen what happens when practices cut compliance corners — and we built our supply infrastructure specifically to help practices avoid those outcomes.

We track regulatory changes across all 50 states and can advise our clients on compliance developments that affect their practice. This is not a service most supply partners offer — because most supply partners are not run by attorneys.

Contact us to discuss your practice's compliance needs →

This content is for informational purposes only and does not constitute legal advice. Consult with qualified legal counsel regarding your specific compliance obligations.